Literature DB >> 7277630

Pseudomonas maltophilia bacteremia in children undergoing open heart surgery.

M C Fisher, S S Long, E M Roberts, J M Dunn, R K Balsara.   

Abstract

Pseudomonas maltophilia was isolated from intraoperative blood cultures in eight of 13 children undergoing open heart surgery during a five-week period. Antibiograms were identical and included resistance to prophylactic antibiotics. The source of the outbreak was traced to contamination of both the calibration device used on the pressure monitoring system and the sensor surface of transducers used in this system. In a mock system, calibration with a contaminated device resulted in recovery of the organism from transducer dome fluid. Dye studies confirmed the integrity of the transducer membrane but demonstrated reflux of dome fluid into the monitoring line fluid. A case-control study revealed no patient- or surgery-related factors predisposing to P maltophilia bacteremia and no excess of morbidity or mortality in patients as a result of bacteremia. The outbreak was confined to patients undergoing open heart surgery and was terminated abruptly by sterilization of transducers and revision of the calibration device.

Entities:  

Mesh:

Year:  1981        PMID: 7277630

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

2.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

Authors:  Hsiao-Chuan Chang; Chiy-Rong Chen; Juey-Wen Lin; Gwan-Han Shen; Kai-Ming Chang; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

Review 6.  Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia.

Authors:  R G Munter; A M Yinnon; Y Schlesinger; C Hershko
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

7.  Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples.

Authors:  M Denton; N J Todd; K G Kerr; P M Hawkey; J M Littlewood
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 9.  Nosocomial infections in the pediatric intensive care unit.

Authors:  R S Baltimore
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr

Review 10.  Unusual nosocomial infections.

Authors:  H C Neu
Journal:  Dis Mon       Date:  1984-10       Impact factor: 3.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.